Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Block Copolymer Brush Layer-Templated Gold Nanoparticles on Nanofibers for Surface-Enhanced Raman Scattering Optophysiology.

Zhu H, Lussier F, Ducrot C, Bourque MJ, Spatz JP, Cui W, Yu L, Peng W, Trudeau LÉ, Bazuin CG, Masson JF.

ACS Appl Mater Interfaces. 2019 Jan 30;11(4):4373-4384. doi: 10.1021/acsami.8b19161. Epub 2019 Jan 18.

PMID:
30615826
2.

Segregation of dopamine and glutamate release sites in dopamine neuron axons: regulation by striatal target cells.

Fortin GM, Ducrot C, Giguère N, Kouwenhoven WM, Bourque MJ, Pacelli C, Varaschin RK, Brill M, Singh S, Wiseman PW, Trudeau LÉ.

FASEB J. 2019 Jan;33(1):400-417. doi: 10.1096/fj.201800713RR. Epub 2018 Jul 16.

PMID:
30011230
3.

Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.

Giguère N, Pacelli C, Saumure C, Bourque MJ, Matheoud D, Levesque D, Slack RS, Park DS, Trudeau LÉ.

J Biol Chem. 2018 Jun 22;293(25):9580-9593. doi: 10.1074/jbc.RA117.000499. Epub 2018 Apr 26.

PMID:
29700116
4.

Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease.

Bourque M, Morissette M, Di Paolo T.

Neuropharmacology. 2019 Mar 15;147:37-54. doi: 10.1016/j.neuropharm.2018.04.005. Epub 2018 Apr 9. Review.

PMID:
29649433
5.

A brief survey of clinicians' perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia.

Lucier KJ, Movilla RV, Parvizian MK, Siddiqui R, Gabriele EH, Bourque M, MacIsaac J, Moorehead PC, Chan AK, Heddle NM, Lane SJ.

Haemophilia. 2018 Mar;24(2):e80-e83. doi: 10.1111/hae.13430. Epub 2018 Feb 8. No abstract available.

PMID:
29418048
6.

Histamine H3 Receptors Decrease Dopamine Release in the Ventral Striatum by Reducing the Activity of Striatal Cholinergic Interneurons.

Varaschin RK, Osterstock G, Ducrot C, Leino S, Bourque MJ, Prado MAM, Prado VF, Salminen O, Rannanpää Née Nuutinen S, Trudeau LE.

Neuroscience. 2018 Apr 15;376:188-203. doi: 10.1016/j.neuroscience.2018.01.027. Epub 2018 Jan 31.

PMID:
29374538
7.

The plasmalogen precursor analog PPI-1011 reduces the development of L-DOPA-induced dyskinesias in de novo MPTP monkeys.

Bourque M, Grégoire L, Di Paolo T.

Behav Brain Res. 2018 Jan 30;337:183-185. doi: 10.1016/j.bbr.2017.09.023. Epub 2017 Sep 14.

PMID:
28917506
8.

Dynamic SERS nanosensor for neurotransmitter sensing near neurons.

Lussier F, Brulé T, Bourque MJ, Ducrot C, Trudeau LÉ, Masson JF.

Faraday Discuss. 2017 Dec 4;205:387-407. doi: 10.1039/c7fd00131b.

PMID:
28895964
9.

Can We Quickly and Thoroughly Assess Pain with the PACSLAC-II? A Convergent Validity Study in Long-Term Care Residents Suffering from Dementia.

Ruest M, Bourque M, Laroche S, Harvey MP, Martel M, Bergeron-Vézina K, Apinis C, Proulx D, Hadjistavropoulos T, Tousignant-Laflamme Y, Léonard G.

Pain Manag Nurs. 2017 Dec;18(6):410-417. doi: 10.1016/j.pmn.2017.05.009. Epub 2017 Aug 24.

PMID:
28843635
10.

Plasmalogen precursor mitigates striatal dopamine loss in MPTP mice.

Miville-Godbout E, Bourque M, Morissette M, Al-Sweidi S, Smith T, Jayasinghe D, Ritchie S, Di Paolo T.

Brain Res. 2017 Nov 1;1674:70-76. doi: 10.1016/j.brainres.2017.08.020. Epub 2017 Aug 19.

PMID:
28830769
11.

Characterization of a Human Point Mutation of VGLUT3 (p.A211V) in the Rodent Brain Suggests a Nonuniform Distribution of the Transporter in Synaptic Vesicles.

Ramet L, Zimmermann J, Bersot T, Poirel O, De Gois S, Silm K, Sakae DY, Mansouri-Guilani N, Bourque MJ, Trudeau LE, Pietrancosta N, Daumas S, Bernard V, Rosenmund C, El Mestikawy S.

J Neurosci. 2017 Apr 12;37(15):4181-4199. doi: 10.1523/JNEUROSCI.0282-16.2017. Epub 2017 Mar 17.

12.

Essential Content for Discharge Instructions in Pediatric Emergency Care: A Delphi Study.

Curran JA, Murphy A, Burns E, Plint A, Taljaard M, MacPhee S, Fitzpatrick E, Bishop A, Chorney J, Bourque M.

Pediatr Emerg Care. 2018 May;34(5):339-343. doi: 10.1097/PEC.0000000000000986.

PMID:
27902672
13.

Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease.

Poirier AA, Côté M, Bourque M, Morissette M, Di Paolo T, Soulet D.

Neurobiol Aging. 2016 Dec;48:61-71. doi: 10.1016/j.neurobiolaging.2016.08.004. Epub 2016 Aug 16.

PMID:
27644075
14.

Training on the DSM-5 Cultural Formulation Interview Improves Cultural Competence in General Psychiatry Residents: A Multi-site Study.

Mills S, Wolitzky-Taylor K, Xiao AQ, Bourque MC, Rojas SM, Bhattacharya D, Simpson AK, Maye A, Lo P, Clark A, Lim R, Lu FG.

Acad Psychiatry. 2016 Oct;40(5):829-34. doi: 10.1007/s40596-016-0551-x. Epub 2016 Apr 19.

PMID:
27093964
15.

Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice.

Miville-Godbout E, Bourque M, Morissette M, Al-Sweidi S, Smith T, Mochizuki A, Senanayake V, Jayasinghe D, Wang L, Goodenowe D, Di Paolo T.

PLoS One. 2016 Mar 9;11(3):e0151020. doi: 10.1371/journal.pone.0151020. eCollection 2016.

16.

Efficacy of Analgesic Treatments to Manage Children's Postoperative Pain After Laparoscopic Appendectomy: Retrospective Medical Record Review.

Manworren RC, McElligott CD, Deraska PV, Santanelli J, Blair S, Ruscher KA, Weiss R, Rader C, Finck C, Bourque M, Campbell B.

AORN J. 2016 Mar;103(3):317.e1-11. doi: 10.1016/j.aorn.2016.01.013.

PMID:
26924376
17.

Presentation and Surgical Management of Duodenal Duplication in Adults.

Jadlowiec CC, Lobel BE, Akolkar N, Bourque MD, Devers TJ, McFadden DW.

Case Rep Surg. 2015;2015:659150. doi: 10.1155/2015/659150. Epub 2015 Dec 30.

18.

Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.

Pacelli C, Giguère N, Bourque MJ, Lévesque M, Slack RS, Trudeau LÉ.

Curr Biol. 2015 Sep 21;25(18):2349-60. doi: 10.1016/j.cub.2015.07.050. Epub 2015 Aug 27.

19.

Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice.

Bourque M, Morissette M, Al Sweidi S, Caruso D, Melcangi RC, Di Paolo T.

Neuroendocrinology. 2016;103(3-4):300-14. doi: 10.1159/000438789. Epub 2015 Jul 24.

20.

GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease.

Côté M, Bourque M, Poirier AA, Aubé B, Morissette M, Di Paolo T, Soulet D.

Neurobiol Dis. 2015 Oct;82:99-113. doi: 10.1016/j.nbd.2015.05.017. Epub 2015 Jun 4.

PMID:
26051538
21.

The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.

Litim N, Bourque M, Al Sweidi S, Morissette M, Di Paolo T.

Neuropharmacology. 2015 Oct;97:86-94. doi: 10.1016/j.neuropharm.2015.05.015. Epub 2015 May 23.

PMID:
26006269
22.

Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1.

Bourque M, Morissette M, Di Paolo T.

Neuropharmacology. 2015 Aug;95:343-52. doi: 10.1016/j.neuropharm.2015.04.006. Epub 2015 Apr 17.

PMID:
25892506
23.

Homeostatic regulation of excitatory synapses on striatal medium spiny neurons expressing the D2 dopamine receptor.

Thibault D, Giguère N, Loustalot F, Bourque MJ, Ducrot C, El Mestikawy S, Trudeau LÉ.

Brain Struct Funct. 2016 May;221(4):2093-107. doi: 10.1007/s00429-015-1029-4. Epub 2015 Mar 18.

PMID:
25782435
24.

Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.

Bourque M, Morissette M, Di Paolo T.

Neurobiol Aging. 2014 Oct;35(10):2347-56. doi: 10.1016/j.neurobiolaging.2014.03.017. Epub 2014 Mar 20.

PMID:
24726471
25.

Combination of vaniprevir with peginterferon and ribavirin significantly increases the rate of SVR in treatment-experienced patients with chronic HCV genotype 1 infection and cirrhosis.

Rodriguez-Torres M, Stoehr A, Gane EJ, Serfaty L, Lawitz E, Zhou A, Bourque M, Bhanja S, Strizki J, Barnard RJ, Hwang PM, DiNubile MJ, Mobashery N.

Clin Gastroenterol Hepatol. 2014 Jun;12(6):1029-37.e5. doi: 10.1016/j.cgh.2013.09.067. Epub 2013 Oct 10.

PMID:
24120953
26.

Evaluation of D1 and D2 dopamine receptor segregation in the developing striatum using BAC transgenic mice.

Thibault D, Loustalot F, Fortin GM, Bourque MJ, Trudeau LÉ.

PLoS One. 2013 Jul 2;8(7):e67219. doi: 10.1371/journal.pone.0067219. Print 2013.

27.

Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors.

Fasano C, Bourque MJ, Lapointe G, Leo D, Thibault D, Haber M, Kortleven C, Desgroseillers L, Murai KK, Trudeau LÉ.

Neuropharmacology. 2013 Apr;67:432-43. doi: 10.1016/j.neuropharm.2012.11.030. Epub 2012 Dec 8.

PMID:
23231809
28.

Glutamate corelease promotes growth and survival of midbrain dopamine neurons.

Fortin GM, Bourque MJ, Mendez JA, Leo D, Nordenankar K, Birgner C, Arvidsson E, Rymar VV, Bérubé-Carrière N, Claveau AM, Descarries L, Sadikot AF, Wallén-Mackenzie Å, Trudeau LÉ.

J Neurosci. 2012 Nov 28;32(48):17477-91. doi: 10.1523/JNEUROSCI.1939-12.2012.

29.

Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease.

Bourque M, Morissette M, Côté M, Soulet D, Di Paolo T.

Neurobiol Aging. 2013 Mar;34(3):887-901. doi: 10.1016/j.neurobiolaging.2012.05.022. Epub 2012 Jun 28.

PMID:
22749492
30.

Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.

Bourque M, Dluzen DE, Di Paolo T.

Front Neuroendocrinol. 2012 Apr;33(2):169-78. doi: 10.1016/j.yfrne.2012.02.003. Epub 2012 Mar 1. Review.

PMID:
22387674
31.

Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways.

Bourque M, Dluzen DE, Di Paolo T.

Neuropharmacology. 2012 Jun;62(7):2363-72. doi: 10.1016/j.neuropharm.2012.02.009. Epub 2012 Feb 21.

PMID:
22369785
32.

Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief report.

Ngai AL, Bourque MR, Lupinacci RJ, Strohmaier KM, Kartsonis NA.

Int J Antimicrob Agents. 2011 Dec;38(6):540-4. doi: 10.1016/j.ijantimicag.2011.07.008. Epub 2011 Sep 16. Review.

PMID:
21925846
33.

Markers associated with sex differences in methamphetamine-induced striatal dopamine neurotoxicity.

Dluzen DE, McDermott JL, Bourque M, Di Paolo T, Darvesh AS, Buletko AB, Laping NJ.

Curr Neuropharmacol. 2011 Mar;9(1):40-4. doi: 10.2174/157015911795017399.

34.

Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.

Al Sweidi S, Sánchez MG, Bourque M, Morissette M, Dluzen D, Di Paolo T.

J Neuroendocrinol. 2012 Jan;24(1):48-61. doi: 10.1111/j.1365-2826.2011.02193.x. Review.

PMID:
21790809
35.

National trends in the surgical management of Meckel's diverticulum.

Ruscher KA, Fisher JN, Hughes CD, Neff S, Lerer TJ, Hight DW, Bourque MD, Campbell BT.

J Pediatr Surg. 2011 May;46(5):893-6. doi: 10.1016/j.jpedsurg.2011.02.024.

PMID:
21616248
36.

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.

Al-Sweidi S, Morissette M, Bourque M, Di Paolo T.

Neuropharmacology. 2011 Sep;61(4):583-91. doi: 10.1016/j.neuropharm.2011.04.031. Epub 2011 May 11.

PMID:
21586296
37.

Somatodendritic dopamine release requires synaptotagmin 4 and 7 and the participation of voltage-gated calcium channels.

Mendez JA, Bourque MJ, Fasano C, Kortleven C, Trudeau LE.

J Biol Chem. 2011 Jul 8;286(27):23928-37. doi: 10.1074/jbc.M111.218032. Epub 2011 May 16.

38.

[Animal assisted therapy in a long-term care nursing home].

Mudzyk A, Bourque M, Guilbert H, Seguin AD, Savoye MJ.

Soins Gerontol. 2011 Mar-Apr;(88):11-3. French.

PMID:
21526533
39.

Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways.

Bourque M, Liu B, Dluzen DE, Di Paolo T.

Psychoneuroendocrinology. 2011 Aug;36(7):955-69. doi: 10.1016/j.psyneuen.2010.12.007. Epub 2011 Jan 13.

PMID:
21236583
40.

Male/Female differences in neuroprotection and neuromodulation of brain dopamine.

Bourque M, Dluzen DE, Di Paolo T.

Front Endocrinol (Lausanne). 2011 Sep 30;2:35. doi: 10.3389/fendo.2011.00035. eCollection 2011.

41.

Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Sánchez MG, Bourque M, Morissette M, Di Paolo T.

CNS Neurosci Ther. 2010 Jun;16(3):e43-71. doi: 10.1111/j.1755-5949.2010.00163.x. Review.

PMID:
20557567
42.

All-terrain vehicle riding among youth: how do they fair?

Campbell BT, Kelliher KM, Borrup K, Corsi J, Saleheen H, Bourque MD, Lapidus G.

J Pediatr Surg. 2010 May;45(5):925-9. doi: 10.1016/j.jpedsurg.2010.02.021.

PMID:
20438928
43.

A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.

Maertens JA, Madero L, Reilly AF, Lehrnbecher T, Groll AH, Jafri HS, Green M, Nania JJ, Bourque MR, Wise BA, Strohmaier KM, Taylor AF, Kartsonis NA, Chow JW, Arndt CA, DePauw BE, Walsh TJ; Caspofungin Pediatric Study Group.

Pediatr Infect Dis J. 2010 May;29(5):415-20. doi: 10.1097/INF.0b013e3181da2171.

PMID:
20431381
44.

Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.

Colombo AL, Ngai AL, Bourque M, Bradshaw SK, Strohmaier KM, Taylor AF, Lupinacci RJ, Kartsonis NA.

Antimicrob Agents Chemother. 2010 May;54(5):1864-71. doi: 10.1128/AAC.00911-09. Epub 2010 Mar 15.

45.

Safety experience with caspofungin in pediatric patients.

Zaoutis T, Lehrnbecher T, Groll AH, Steinbach WJ, Jafri HS, Maertens J, Ngai AL, Chow JW, Taylor AF, Strohmaier KM, Bourque M, Bradshaw SK, Petrecz M, Kartsonis NA.

Pediatr Infect Dis J. 2009 Dec;28(12):1132-5. doi: 10.1097/INF.0b013e3181af5a15.

PMID:
19779392
46.

Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems.

Ji J, Bourque M, Di Paolo T, Dluzen DE.

Biochem Pharmacol. 2009 Dec 1;78(11):1401-11. doi: 10.1016/j.bcp.2009.07.004. Epub 2009 Jul 15.

PMID:
19615345
47.

Scrotal abcess mimicking testicular torsion in a premature infant.

Arias-Camison JM, Desilva HN, Panthagani I, Twohig MT, Bourque MD.

Conn Med. 2009 Apr;73(4):215-6.

PMID:
19413082
48.

Neuroprotective actions of sex steroids in Parkinson's disease.

Bourque M, Dluzen DE, Di Paolo T.

Front Neuroendocrinol. 2009 Jul;30(2):142-57. doi: 10.1016/j.yfrne.2009.04.014. Epub 2009 May 3. Review.

PMID:
19410597
49.

Developmental and target-dependent regulation of vesicular glutamate transporter expression by dopamine neurons.

Mendez JA, Bourque MJ, Dal Bo G, Bourdeau ML, Danik M, Williams S, Lacaille JC, Trudeau LE.

J Neurosci. 2008 Jun 18;28(25):6309-18. doi: 10.1523/JNEUROSCI.1331-08.2008.

50.

Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.

Bourque M, Liu B, Dluzen DE, Di Paolo T.

Biochem Pharmacol. 2007 Nov 1;74(9):1413-23. Epub 2007 Jul 14.

PMID:
17825264

Supplemental Content

Loading ...
Support Center